AI-Guided Genome Editor Discovery
Machine-learning models mine and generate protein and genomic sequence space to surface new RNA-guided systems and design functional editors beyond those found in nature.
Developed mainly in: United StatesImpacting: North America, Europe and China
Anthropic has formed an internal life sciences research group with a wet lab, using Claude to mine DNA sequence databases for uncharacterized protein families and generate testable hypotheses. In early work, the model flagged and helped characterize a previously unknown enzyme system featuring CRISPR-like repeat architecture, working from only broad human direction.
This is one of 24 signals scored in our latest scan.
Track Them Free For 14 Days →Since we flagged this
First flagged
1 July 2026 · score 9.0/10
Corroborating sources since flagging
34
Latest signals
Tracked from 3 signals, each traced to its source.
- Viral ancestor of CRISPR found using previously unknown gapped DNA-recognition code
Timesofindia · 7 Oct 2026
- AI model identifies uncharacterized bacterial enzyme system resembling CRISPR from genomic data
Anthropic · 24 Sept 2026
- Design of highly functional genome editors by modelling CRISPR–Cas sequences
Preview-www · 1 Jul 2026
In the full record
Evolution
Score over time, Score Jumps and how the evidence built up since the first signal.
Thesis
Paradigm Shift, Commercial Viability, signal strength and the driver of the change.
Why this innovation matters
The full analysis: what is shifting, who is affected and the second-order effects.
Forecasted Hypothesis
What would strengthen this innovation, and what would weaken it.
Exposure
Companies and publicly listed stock symbols linked to this innovation.
Every signal
Each signal with its date, score, flags and original source.
Open the full record free for 14 days → No card needed.
More in Biotech
Other innovations the engine is currently tracking in this industry.
- Virtual Trial Outcome Prediction7.0/ 10 · 2 signals
- Multi-Receptor Incretin Co-Agonists6.8/ 10 · 5 signals
- Programmable RNA And Expression Control7.7/ 10 · 3 signals
- Multivalent Seasonal Respiratory mRNA Vaccines6.5/ 10 · 2 signals
- Novel Food Approval Pathways For Cultivated Meat6.9/ 10 · 7 signals
- Clinical Genome-Editing Therapeutics7.8/ 10 · 6 signals
Track every innovation, free for 14 days
Full Analyst access from the first day. No card. Then subscribe to keep it.
- The radar: every innovation, ranked by Disruption Score
- Tracked evolution: score over time, Score Jumps and how the evidence built up
- Thesis and analysis: Commercial Viability, Paradigm Shift, why it matters, what would change it
- Geography: where each innovation is developed and where it has impact
- Exposure: the companies and public stock symbols behind each innovation
- Every signal with its source, and what moved since your last visit
- Email alerts when an innovation moves: First Signal, Score Jump and briefings
Disclaimer: The information provided on this page is for educational and informational purposes only. It does not constitute financial advice, investment recommendations, or an offer to buy or sell securities. Stock data shown is illustrative and may not reflect real-time prices. Always conduct your own research and consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.